featured
Erenumab for Preventing High-Frequency Migraine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Erenumab in the Prevention of High-Frequency Episodic and Chronic Migraine: Erenumab in Real Life in Italy (EARLY), the First Italian Multicenter, Prospective Real-Life Study
Headache 2020 Dec 18;[EPub Ahead of Print], P Barbanti, C Aurilia, G Egeo, L Fofi, S Cevoli, B Colombo, M Filippi, F Frediani, F Bono, L Grazzi, A Salerno, B Mercuri, A Carnevale, C Altamura, F VernieriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.